Top Markets
Coin of the day
Stemtech Corporation Stemtech Corporation

Stemtech Corporation

STEK
Rang in Aktien #41613
Stemtech Corporation is a pioneering company specializing in stem cell... Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-10
Marktkapitalisierung
$14.62K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-99.61%
Land
US
Handel Stemtech Corporation (STEK)

Kategorie

P/B-Verhältnis für Stemtech Corporation (STEK)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Stemtech Corporation beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Stemtech Corporation von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber